Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03211793 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Mesenchymal Stromal Cells as Treatment for Digital Ulcers in Systemic Sclerosis

Study acronym: MANUS
StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Notable Primary and study completion dates: Nov 1, 2024 to Nov 1, 2026v6
  2. Notable Primary and study completion dates: Nov 1, 2023 to Nov 1, 2024v5
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Nov 1, 2020 to Nov 1, 2023
    • Start date changed from estimate of Nov 2018 to Oct 6, 2021
    • Site details revised
    v4
  4. Notable Primary and study completion dates: Sep 1, 2019 to Nov 1, 2020
    • Start date: Jan 2018 to Nov 2018
    • Trial status: Recruiting to Not Yet Recruiting
    • Site details revised
    v3
  5. Notable Start date: Sep 2017 to Jan 2018v2
  6. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
324 trials monitored
See 13 trials at risk
The MANUS Trial aims to examine the safety, feasibility and potential efficacy of intramuscularly injected allogeneic mesenchymal stromal cells as treatment for digital ulcers of systemic sclerosis.
Trial Details
NCT Number NCT03211793
Lead Sponsor UMC Utrecht
Collaborators: ZonMw: The Netherlands Organisation for Health Research and Development
Conditions
(from sponsor)
Systemic Sclerosis, Digital Ulcer
Related terms digital ulcers, Scleroderma, Diffuse, Scleroderma, Systemic, Vascular Diseases
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov